J. Hardy

发表

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

T. Powles, M. Dowsett, J. Davey, 1989, British Journal of Cancer.

A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain.

R. A’Hern, J. Hardy, K. Broadley, 2001, Journal of pain and symptom management.

The use of the Rotterdam Symptom Checklist in palliative care.

R. A’Hern, J. Hardy, E. Rees, 1999, Journal of pain and symptom management.

Preliminary Development and Validation of a New End-of-Life Patient-Reported Outcome Measure Assessing the Ability of Patients to Finalise Their Affairs at the End of Life

D. Currow, N. McCaffrey, J. Hardy, 2014, PloS one.

patients unable to give consent Novel consent process for research in dying

J. Hardy, E. Rees, 2007 .

Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction

M. Gore, G. Hanks, R. A’Hern, 1998, Palliative medicine.

The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK

R. A’Hern, J. Hardy, K. Broadley, 1998, Palliative medicine.

A Review of the COX-2 Inhibitors

J. Hardy, Shamsul Shah, S. Shah, 2001 .

How many tests are required in the diagnosis of palpable breast abnormalities?

M. Williams, T. Powles, I. Judson, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer.

J. Hardy, T. Powles, J. Husband, 1990, British Journal of Cancer.

Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery).

P. Vayne-Bossert, J. Hardy, A. Haywood, 2017, The Cochrane database of systematic reviews.

A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care

J. Hardy, K. Gilshenan, Clare White, 2008, Supportive Care in Cancer.

Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine

J. Hardy, O. Spruyt, D. Currow, 2014, Internal medicine journal.

What do palliative care patients and their relatives think about research in palliative care?—a systematic review

J. Hardy, Clare White, 2010, Supportive Care in Cancer.

Principles of palliative medicine research

J. Hardy, P. Glare, Clare White, 2009 .

Placebo-controlled trials in palliative care: the argument for

J. Hardy, J. Hardy, 1997, Palliative medicine.

Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?

J. Hardy, B. Charles, R. Norris, 2014, Supportive Care in Cancer.

Acupuncture and acupressure for chemotherapy-induced nausea and vomiting: A systematic review

J. Hardy, E. Chang, C. McKeon, 2013 .

Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer.

J. Hardy, A. Haywood, Sohil Khan, 2020, The Cochrane database of systematic reviews.

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

P. Yates, J. Hardy, A. Haywood, 2020, Trials.

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

P. Yates, J. Hardy, A. Haywood, 2019, BMC Palliative Care.

An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care

J. Hardy, R. Greer, P. Good, 2019, Journal of palliative medicine.

Phase III randomised double-blind controlled trial of oral risperidone, haloperidol or placebo with rescue subcutaneous midazolam for delirium management in palliative care

B. Draper, D. Currow, B. Fazekas, 2015 .

Designing and conducting randomized controlled trials in palliative care: A summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative

A. Abernethy, T. Luckett, D. Currow, 2012, Palliative medicine.

A prospective survey of the use of dexamethasone on a palliative care unit

P. Stone, R. Burman, J. Hardy, 2001, Palliative medicine.

Case report: Magnetic resonance imaging of spinal amyloid

T. Powles, J. Hardy, M. Williams, 1989 .

The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer.

J. Hardy, K. Gilshenan, Clare White, 2010, Journal of pain and symptom management.

Opioid addiction and misuse in adult and adolescent patients with cancer

J. Hardy, R. Pinkerton, 2017, Internal medicine journal.

Successful Use of Ketamine Infusion in the Treatment of Intractable Cancer Pain in an Outpatient

J. Hardy, A. Herbert, E. Reymond, 2007 .

Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?

J. Hardy, S. Hennig, A. Haywood, 2017, Clinical therapeutics.

Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer.

J. Hardy, A. Haywood, P. Good, 2015, Clinical therapeutics.

Development, validation and application of an HPLC-MS/MS method for the determination of fentanyl and nor-fentanyl in human plasma and saliva.

J. Hardy, A. Haywood, R. Norris, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?

J. Hardy, B. Charles, R. Norris, 2012, Supportive Care in Cancer.

Vitamin D deficiency in patients with malignancy in Brisbane

J. Hardy, A. Morton, A. Morton, 2014, Supportive Care in Cancer.

The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancer.

M. Williams, I. Judson, I. Smith, 1990, British Journal of Cancer.

Current Issues in Cancer Palliative care

J. Hardy, C. Davis, 1994 .

Sector-wide approach to phase III studies

J. Hardy, D. Currow, 2012, Palliative medicine.

Integration of oncology and palliative care: setting a benchmark

P. Vayne-Bossert, J. Hardy, P. Good, 2017, Supportive Care in Cancer.

Chemoprevention of breast cancer

T. Powles, M. Dowsett, J. Davey, 1989, Breast Cancer Research and Treatment.

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

J. Hardy, R. Olson, P. Good, 2022, Trials.

The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.

C. Nikles, G. Mitchell, D. Currow, 2015, Journal of pain and symptom management.

Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol

J. Nikles, G. Mitchell, D. Currow, 2013, BMC Palliative Care.

Can the LANSS scale be used to classify pain in chronic cancer pain trials?

D. Currow, B. Fazekas, M. Agar, 2013, Supportive Care in Cancer.

Castrate-resistant prostate cancer: lessons learnt from a pilot study in the palliative care research population.

P. Vayne-Bossert, J. Hardy, P. Good, 2018, International journal of palliative nursing.

Practice review: Evidence-based quality use of corticosteroids in the palliative care of patients with advanced cancer

J. Hardy, A. Haywood, L. Sallnow, 2021, Palliative medicine.

Experience in the use of the palliative care outcome scale

R. A’Hern, J. Hardy, K. Broadley, 2005, Supportive Care in Cancer.

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer.

I. Judson, J. Hardy, S. Ashley, 1991, British Journal of Cancer.

Reply to K. Jackson et al and W. Leppert.

D. Currow, B. Fazekas, M. Agar, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Progressing an evidence-base beyond case series.

D. Currow, M. Agar, J. Hardy, 2011, Journal of palliative medicine.

Palliative care in paediatric oncology

J. Hardy, R. Hain, 2004 .

Barriers to the best care of the dying in Queensland, Australia.

P. Yates, J. Hardy, K. Gilshenan, 2008, Journal of palliative medicine.

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients

J. Hardy, M. Albertsson, G. Stathopoulos, 2002, Supportive Care in Cancer.

Creating a palliative care research network in Queensland, Australia – is this the answer?

P. Yates, J. Hardy, K. Dingle, 2005 .

Review of the quality of complementary medicines information resources: Summary report

C. Mar, A. Dean, K. Steadman, 2009 .

Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?

J. Hardy, P. Good, Sarah Lord, 2022, Current Treatment Options in Oncology.

Interests and conflicts when writing, reviewing and editing papers on voluntary assisted dying

J. Hardy, J. Philip, 2021, Internal medicine journal.

CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.

A. Somogyi, D. Currow, J. Hardy, 2015, British journal of clinical pharmacology.

Consent for trials in palliative care

J. Hardy, 2000, The Lancet.

Novel consent process for research in dying patients unable to give consent

J. Hardy, E. Rees, 2003, BMJ : British Medical Journal.

Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer.

L. Haupt, H. Sutherland, C. L. Albury, 2022, Pharmacogenomics.

The effect of cimetidine, phenobarbitone and buthionine sulphoximine on the disposition of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulphonylamino) phenylamino]-4-acridinecarboxamide (CI-921) in the rabbit

J. Hardy, J. Paxton, P. Evans, 2004, Cancer Chemotherapy and Pharmacology.

Assessing transfusion practice in elective surgical patients: a baseline audit

J. Hardy, J. Duff, J. Munday, 2019, ISBT Science Series.

Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)

J. Hardy, R. Greer, P. Good, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Attitudes of patients with advanced cancer toward research.

J. Hardy, Clare White, 2009, Journal of pain and symptom management.

Evaluation of palliative care. Recruitment figures may be low.

J. Hardy, J. Ling, K. Penn, 1995, BMJ.

‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer

J. Hardy, R. Olson, P. Good, 2022, Health expectations : an international journal of public participation in health care and health policy.

Survival following palliative percutaneous nephrostomy tube insertion in patients with malignant ureteric obstruction: Validating a prognostic model

J. Hardy, P. Good, B. Gunawan, 2021, Progress in Palliative Care.

The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer

Mellar P. Davis, J. Hardy, 2021, Current Treatment Options in Oncology.

Interventional options for the management of refractory cancer pain—what is the evidence?

P. Vayne-Bossert, J. Hardy, P. Gray, 2016, Supportive Care in Cancer.

Pharmacological options for the management of refractory cancer pain—what is the evidence?

J. Hardy, K. Kindl, P. Good, 2015, Supportive Care in Cancer.

38 – Symptom management in the last days of life

J. Hardy, S. L. Librach, 2011 .

Sedation in terminally ill patients

J. Hardy, 2000, The Lancet.

Non-Steroidal Anti-inflammatory Drugs in Cancer Pain: A Review of the Literature as Relevant to Palliative Care

J. Hardy, Shamsul Shah, S. Shah, 2001 .

2017 IAPCON Abstracts

Thenmozhi, D. Munday, K. Ramchandran, 2017, Indian Journal of Palliative Care.

An audit of morphine prescribing in a specialist cancer hospital

J. Hardy, R. Turner, Judith K. Clark, 1994, Palliative medicine.

Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study.

R. A’Hern, J. Hardy, K. Broadley, 2005, Journal of palliative medicine.

Treatment of Nausea and Vomiting in Terminally I11 Cancer Patients

P. Yates, K. Clark, J. Hardy, 2012, Drugs.

An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer

R. A’Hern, J. Hardy, S. Shah, 2005, Supportive Care in Cancer.

End of life care in patients with malignant disease.

P. Stone, J. Hardy, E. Rees, 2001, European journal of cancer.

Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care.

J. Nikles, S. Vohra, G. Mitchell, 2011, Journal of clinical epidemiology.

Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer.

J. Hardy, J. Mansi, G. van Tienhoven, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of a fentanyl transdermal adhesion scoring tool for use in clinical practice.

J. Hardy, A. Haywood, P. Good, 2015, Journal of pain and symptom management.

Prioritising drugs for single patient (n-of-1) trials in palliative care

J. Nikles, G. Mitchell, J. Hardy, 2009, Palliative medicine.

Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).

J. Hardy, V. Harvey, B. Baguley, 1988, Cancer research.

Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection.

J. Hardy, S. Hennig, A. Haywood, 2016, Talanta.

Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy

J. Hardy, V. Harvey, 1989 .

Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study

J. Nikles, G. Mitchell, D. Currow, 2015, Palliative medicine.

Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trials

J. Nikles, G. Mitchell, D. Currow, 2013, BMC Palliative Care.

Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer.

G. Mitchell, J. Hardy, S. Carmont, 2010, Journal of palliative medicine.

Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer.

J. Hardy, V. Harvey, B. Baguley, 1991, European journal of cancer.

Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial

B. Draper, D. Currow, B. Fazekas, 2017, JAMA internal medicine.

Corticosteroids for the management of cancer-related pain in adults.

J. Hardy, A. Haywood, Sohil Khan, 2015, The Cochrane database of systematic reviews.

A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms

J. Hardy, P. Good, S. Heng, 2018, Palliative medicine.

Fatigue in advanced cancer: a prospective controlled cross-sectional study

P. Stone, R. A’Hern, J. Hardy, 1999, British Journal of Cancer.

Letter to the editor: Subcutaneous sufentanil for palliative care patients in a hospital setting

J. Hardy, Clare White, A. Boyd, 2008, Palliative medicine.

Opioid analgesics for severe cancer pain

J. Hardy, P. Good, 2012 .

Placebo and nocebo effects in randomized controlled trials: the implications for research and practice.

D. Currow, J. Hardy, C. Sanderson, 2013, Journal of pain and symptom management.

Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.

J. Plummer, D. Currow, B. Fazekas, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial.

D. Currow, B. Fazekas, N. McCaffrey, 2016, Australian health review : a publication of the Australian Hospital Association.

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.

P. Ellis, M. Nicolson, D. Talbot, 1995, British Journal of Cancer.

Clinical study and pharmacokinetics of lonidamine in advanced non-small cell lung cancer.

I. Smith, D. Newell, J. Hardy, 1991, European journal of cancer.

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.

I. Smith, J. Hardy, I. Smith, 1989, British Journal of Cancer.

Outcome of malignant spinal cord compression at a cancer center: implications for palliative care services.

R. A’Hern, J. Hardy, J. Cowap, 2000, Journal of pain and symptom management.

Defining refractory pain in cancer for clinicians and researchers.

D. Currow, J. Hardy, O. Spruyt, 2012, Journal of palliative medicine.

Guidelines for Subcutaneous Infusion Device Management in Palliative Care

P. Yates, J. Hardy, T. Hall, 2010 .

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

Paul Glare, G. Mitchell, D. Currow, 2018, BMC Cancer.

Saliva versus Plasma for Pharmacokinetic and Pharmacodynamic Studies of Fentanyl in Patients with Cancer.

J. Hardy, A. Haywood, P. Good, 2015, Clinical therapeutics.

A Theoretically Informed Approach to Support the Implementation of Pre-Operative Anemia and Iron Deficiency Screening, Evaluation, and Management Pathways: Protocol for a Type Two Hybrid-Effectiveness Study

J. Hardy, H. Tuffaha, C. Hurst, 2021, Journal of multidisciplinary healthcare.

Overcoming barriers to evidence-based patient blood management: a restricted review

J. Hardy, J. Duff, J. Munday, 2020, Implementation science : IS.

Single-patient multiple crossover studies to determine the effectiveness of paracetamol in relieving pain suffered by patients with advanced cancer taking regular opioids: A pilot study

J. Nikles, G. Mitchell, D. Currow, 2016, Palliative Medicine.

Preoperative Anemia Screening and Treatment Practices in Patients Having Total Joint Replacement Surgery: A Retrospective, Observational Audit

J. Hardy, C. Hurst, J. Duff, 2020, Journal of blood medicine.

Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.

A. Abernethy, D. Currow, B. Fazekas, 2015, Journal of pain and symptom management.

Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management

J. Hardy, S. Hennig, A. Haywood, 2016, Journal of clinical pharmacology.

Therapeutic Challenges in Cancer Pain Management: A Systematic Review of Methadone

J. Hardy, A. Haywood, Sohil Khan, 2014, Journal of pain & palliative care pharmacotherapy.

Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?

R. A’Hern, J. Hardy, S. Shah, 2002, British Journal of Cancer.

Opioids for cancer pain

J. Hardy, Friedemann Nauch, 2009 .

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

J. Hardy, H. Tuffaha, C. Hurst, 2023, Transfusion.

Preoperative Anemia and Iron Deficiency Screening, Evaluation and Management: Barrier Identification and Implementation Strategy Mapping

J. Hardy, J. Duff, J. Munday, 2020, Journal of multidisciplinary healthcare.

Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults.

P. Vayne-Bossert, J. Hardy, A. Haywood, 2017, The Cochrane database of systematic reviews.

A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease

J. Hardy, C. Flatley, K. Gibbons, 2016, Supportive Care in Cancer.

A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer.

P. Stone, R. A’Hern, J. Hardy, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy.

P. Stone, R. A’Hern, J. Hardy, 2001, Journal of pain and symptom management.

Fatigue in patients with cancer.

P. Stone, J. Hardy, M. Richards, 1998, European journal of cancer.

A good death in hospital

J. Hardy, P. Good, 2014, Internal medicine journal.

Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life

L. Haupt, H. Sutherland, C. L. Albury, 2022, Scientific Reports.

Editorial: Lymphoedema - prevention rather than cure

J. Hardy, 1991 .

Lymphoedema--prevention rather than cure.

M. Baum, J. Hardy, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

A pilot study of intraperitoneal bevacizumab for the palliation of malignant ascites

J. Hardy, D. Munster, C. Shannon, 2017, Asia-Pacific journal of clinical oncology.

Prediction of survival in a hospital-based continuing care unit.

R. A’Hern, M. Saunders, J. Hardy, 1994, European journal of cancer.

A good death down under

J. Hardy, R. Vora, 2004, Internal medicine journal.

Emotionally reflexive labour in end-of-life communication.

J. Hardy, R. Olson, P. Good, 2020, Social science & medicine.

Quality use of medicines: Oral corticosteroids in advanced cancer

J. Hardy, K. Kindl, P. Good, 2019, Palliative Medicine.

Evidence-based complementary medicine for palliative cancer care: does it make sense?

E. Ernst, J. Hardy, J. Filshie, 2003, Palliative medicine.

Ea versus Sham Acupuncture and no Acupuncture for the Control of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot Study

J. Hardy, C. McKeon, K. Gibbons, 2015, Acupuncture in medicine : journal of the British Medical Acupuncture Society.

Thioridazine in the management of cancer-related sweating.

J. Hardy, J. Cowap, 1998, Journal of pain and symptom management.

Fatigue in patients with prostate cancer receiving hormone therapy.

P. Stone, R. Huddart, R. A’Hern, 2000, European journal of cancer.

The pharmacokinetics of oral lonidamine in breast and lung cancer patients.

I. Smith, D. Newell, J. Hardy, 1991, Seminars in oncology.

Corticosteroids as Co-analgesics With Opioids for Cancer-Related Pain: A Feasibility Study.

J. Hardy, P. Good, Amanda Fischer, 2017, Journal of pain and symptom management.

Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles

M. Hjermstad, M. Bennett, D. Bouhassira, 2017, British journal of anaesthesia.

The lipophilic opioids: Fentanyl, alfentanil, sufentanil and remifentanil

J. Hardy, T. Hall, 2009 .

Combination of tamoxifen, aminoglutethimide, danazol and medroxyprogesterone acetate in advanced breast cancer.

T. Powles, R. Coombes, I. Judson, 1990, European journal of cancer.

Symptom management in palliative care

P. Yates, J. Hardy, 2008 .

Developing guidelines for syringe driver management.

P. Yates, J. Hardy, Victoria J Kain, 2006, International journal of palliative nursing.

Guidelines for syringe driver management in palliative care

P. Yates, J. Hardy, Victoria J Kain, 2006 .

What influences participation in clinical trials in palliative care in a cancer centre?

J. Hardy, E. Rees, J. Ling, 2000, European journal of cancer.

Negotiating Futility, Managing Emotions

A. Broom, P. Yates, J. Hardy, 2015, Qualitative health research.

Impact of Opioid Therapy on Sleep and Respiratory Patterns in Adults With Advanced Cancer Receiving Palliative Care.

J. Hardy, S. Bowler, P. Good, 2017, Journal of pain and symptom management.

Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD).

R. A’Hern, J. Hardy, P. Ling, 1995, British Journal of Cancer.

An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer

J. Hardy, K. Gibbons, P. Good, 2017, Supportive Care in Cancer.

Gatekeeping from palliative care research trials

J. Hardy, Clare White, 2008 .

Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein

J. Hardy, A. Haywood, R. Norris, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Oral water-soluble contrast (Gastrografin) for malignant bowel obstruction: open label pilot study

J. Hardy, P. Good, K. Foster, 2022, BMJ supportive & palliative care.

Prevalence of QTc prolongation in patients with advanced cancer receiving palliative care - a cause for concern?

J. Hardy, J. Philip, K. Gibbons, 2019, Journal of pain and symptom management.

Planning phase III multi-site clinical trials in palliative care: the role of consecutive cohort audits to identify potential participant populations

J. Plummer, D. Currow, M. Agar, 2010, Supportive Care in Cancer.

Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives.

J. Hardy, K. Gilshenan, C. Pinkerton, 2008, European journal of cancer.

Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7)

M. King, D. Currow, B. Fazekas, 2019, Supportive Care in Cancer.

Using national health policies to improve access to palliative care medications in the community.

D. Currow, J. Hardy, P. Ravenscroft, 2009, Journal of pain and symptom management.

Harms From Haloperidol for Symptom Management in Palliative Care-a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies.

D. Currow, H. Matsuoka, B. Fazekas, 2019, Journal of pain and symptom management.

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

G. Mitchell, D. Currow, P. Yates, 2018, BMC Cancer.

A randomised, controlled, double blind study of oral methotrimeprazine versus oral haloperidol in patients with cancer and nausea not related to anticancer therapy

P. Yates, H. Skerman, J. Hardy, 2017 .

Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial

G. Mitchell, D. Currow, P. Yates, 2019, BMJ Open.

Symptom Clusters in Men With Castrate-Resistant Prostate Cancer.

P. Yates, H. Skerman, P. Vayne-Bossert, 2017, Journal of pain and symptom management.

Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials

J. Hardy, R. Olson, P. Good, 2022, BMJ Supportive & Palliative Care.

Medicinal cannabis use in palliative care.

J. Hardy, A. Herbert, 2021, Australian Journal of General Practice.

Balancing patient confidentiality and the needs of carers

J. Hardy, C. White, 2009, Internal medicine journal.

phase Iii Randomized Double-blind Controlled Trial of Oral Risperidone, Haloperidol or Placebo with Rescue Subcutaneous Midazolam for Delirium Management in Palliative Care : abstract number: Fc62

B. Draper, D. Currow, B. Fazekas, 2016 .

Role of pharmacogenomics in pain therapy: Focus on opioids

A. Somogyi, J. Hardy, 2010 .

Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain

D. Currow, B. Fazekas, N. McCaffrey, 2018, Palliative medicine.

Insurance cover for research in independent hospices

J. Hardy, C. Lucas, 2003, Palliative medicine.

Using national health policies to improve access to palliative care medications in the community.

D. Currow, J. Hardy, P. Ravenscroft, 2009, Journal of pain and symptom management.

Magnetic resonance imaging of spinal amyloid.

T. Powles, J. Hardy, M. Williams, 1989, Clinical radiology.

CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.

A. Somogyi, D. Currow, J. Hardy, 2015, British journal of clinical pharmacology.

End‐of‐life decision‐making in intensive care: the case for an international standard or a standard of care?

J. Hardy, S. Townsend, S. Townsend, 2008, Internal medicine journal.

Planning phase III multi-site clinical trials in palliative care: the role of consecutive cohort audits to identify potential participant populations

J. Plummer, D. Currow, M. Agar, 2010, Supportive Care in Cancer.

Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis

J. Hardy, R. Olson, Nathalia Cordeiro da Costa, 2023, Sociology of health & illness.